resveratrol has been researched along with Coronary Heart Disease in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howe, PRC; Thaung Zaw, JJ; Wong, RHX | 1 |
| Huo, X; Li, C; Meng, Q; You, B; Zhang, T | 1 |
| Weiskirchen, R; Weiskirchen, S | 1 |
| Maulik, N; Penumathsa, SV | 1 |
| Szabó, G | 1 |
| Bianchi, C; Boodhwani, M; Clements, RT; Coady, MA; Feng, J; Laham, RJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW | 1 |
| Hsieh, TC; Wu, JM | 1 |
| Wu, Y; Zhang, F | 1 |
| Frank, GC | 1 |
| Granados-Soto, V | 1 |
| Chen, JK; Hung, LM; Su, MJ | 1 |
| Agewall, S; Cruz, MN; Kublickiene, K; Logman, H; Luksha, L; Poston, L | 1 |
| Djukanovic, B; Gojkovic-Bukarica, L; Heinle, H; Markovic-Lipkovski, J; Nezic, D; Novakovic, A; Peric, M | 1 |
| Lecour, S; Opie, LH | 1 |
| Diamandis, EP; Goldberg, DM; Hahn, S; Pace-Asciak, CR; Soleas, G | 1 |
| Frankel, EN; Kinsella, JE; Waterhouse, AL | 1 |
| Daniel, O; Frischknecht, P; Meier, MS; Schlatter, J | 1 |
| Bertelli, A; Bertelli, AA; Das, DK; Engelman, RM; Maulik, G; Ray, PS; Sato, M | 1 |
| Bruder, JL; Hsieh, TC; Huang, YZ; Wang, ZR; Wu, JM; Zou, JG | 1 |
| Simonyi, A; Sun, AY; Sun, GY | 1 |
11 review(s) available for resveratrol and Coronary Heart Disease
| Article | Year |
|---|---|
Postmenopausal health interventions: Time to move on from the Women's Health Initiative?
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Coronary Disease; Dementia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Phytoestrogens; Postmenopause; Resveratrol; Risk Assessment; Time Factors; Women's Health | 2018 |
Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?
Topics: Coronary Disease; Diet; Dietary Supplements; Fruit; Glycosides; Humans; Inflammation; Metabolic Diseases; Neurodegenerative Diseases; Phytotherapy; Plant Extracts; Polyphenols; Resveratrol; Stilbenes; Wine | 2016 |
Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.
Topics: Animals; Coronary Disease; Diabetes Mellitus; Endothelial Cells; Glucose; Glucose Transporter Type 4; Heart; Humans; Hypercholesterolemia; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2009 |
Resveratrol: a cardioprotective substance.
Topics: Animals; Cardiotonic Agents; Coronary Disease; Humans; Resveratrol; Stilbenes; Wine | 2011 |
From sandwiches to center stage. Peanuts pack a powerful nutritional punch.
Topics: Arachis; Coronary Disease; Fatty Acids, Monounsaturated; Health Promotion; Humans; Menu Planning; Neoplasms; Phytosterols; Resveratrol; Stilbenes; Stroke | 2003 |
Pleiotropic effects of resveratrol.
Topics: Antineoplastic Agents, Phytogenic; Coronary Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gene Expression; Isoenzymes; Neoplasms; Pain; Prostaglandin-Endoperoxide Synthases; Resveratrol; Stilbenes | 2003 |
The red wine hypothesis: from concepts to protective signalling molecules.
Topics: Alcohol Drinking; Animals; Arteriosclerosis; Coronary Disease; Female; Flavonoids; Humans; Hypertension; Male; Mice; Phenols; Platelet Aggregation; Platelet Aggregation Inhibitors; Polyphenols; Rats; Resveratrol; Risk Factors; Stilbenes; Wine | 2007 |
Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides.
Topics: Animals; Coronary Disease; Coumarins; Ecology; Flavonoids; Herbicides; Humans; Phenols; Plants; Resveratrol; Stilbenes | 1999 |
Cardioprotection of red wine: role of polyphenolic antioxidants.
Topics: Antioxidants; Coronary Disease; Flavonoids; Humans; Phenols; Plant Extracts; Platelet Aggregation Inhibitors; Polymers; Polyphenols; Reperfusion Injury; Resveratrol; Stilbenes; Wine | 1999 |
Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review).
Topics: Animals; Antioxidants; Coronary Disease; Humans; Resveratrol; Stilbenes; Wine | 2001 |
The "French Paradox" and beyond: neuroprotective effects of polyphenols.
Topics: Antioxidants; Coronary Disease; Flavonoids; France; Free Radicals; Humans; Neurodegenerative Diseases; Neurons; Oxidative Stress; Phenols; Polymers; Polyphenols; Resveratrol; Stilbenes; Vitis | 2002 |
1 trial(s) available for resveratrol and Coronary Heart Disease
| Article | Year |
|---|---|
Acute responses to phytoestrogens in small arteries from men with coronary heart disease.
Topics: Administration, Oral; Adult; Aged; Arteries; Coronary Disease; Genistein; Humans; Male; Middle Aged; Nitric Oxide; Phytoestrogens; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Vasodilation | 2006 |
8 other study(ies) available for resveratrol and Coronary Heart Disease
| Article | Year |
|---|---|
Resveratrol Effects on a Diabetic Rat Model with Coronary Heart Disease.
Topics: Animals; Blotting, Western; China; Cholesterol; Coronary Disease; Diabetes Mellitus, Experimental; Disease Models, Animal; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Insulin; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Male; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
A glass of red wine to improve mitochondrial biogenesis? Novel mechanisms of resveratrol.
Topics: Antioxidants; Coronary Disease; Humans; Mitochondria; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha; Wine | 2009 |
Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillaries; Chronic Disease; Coronary Circulation; Coronary Disease; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Male; Microcirculation; Myocardial Ischemia; Myocardium; Neovascularization, Physiologic; Perfusion; Resveratrol; Signal Transduction; Stilbenes; Swine; Vascular Endothelial Growth Factor A | 2010 |
Resveratrol may be an effective prophylactic agent for ischemic stroke.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Brain Ischemia; Coronary Disease; Cyclooxygenase Inhibitors; Free Radical Scavengers; Humans; Neuroprotective Agents; Nitric Oxide; Resveratrol; Stilbenes; Stroke; Wine | 2011 |
Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Creatine Kinase; Gene Expression; Heart Rate; L-Lactate Dehydrogenase; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2004 |
The mechanism of endothelium-independent relaxation induced by the wine polyphenol resveratrol in human internal mammary artery.
Topics: 4-Aminopyridine; Anti-Arrhythmia Agents; Charybdotoxin; Coronary Artery Bypass; Coronary Disease; Glyburide; Humans; Male; Mammary Arteries; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; Neurotoxins; Potassium Channel Blockers; Potassium Channels; Resveratrol; Scorpion Venoms; Stilbenes; Tetraethylammonium; Vasodilation; Vasodilator Agents; Wine | 2006 |
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease.
Topics: Arteriosclerosis; Coronary Disease; Eicosanoids; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Quercetin; Resveratrol; Stilbenes; Wine | 1995 |
Inhibition of human LDL oxidation by resveratrol.
Topics: Coronary Disease; Humans; Lipoproteins, LDL; Oxidation-Reduction; Resveratrol; Stilbenes; Wine | 1993 |